Download sample report: https://www.delveinsight.com/report-store/burn-pain-market?utm_source=reportutm_medium=promotionutm_campaign=hpr
Key Findings of the Burn Injury Market Report:
- The US recorded the highest number of burn pain treatments, leading the market share among the 7MM (US, EU5, Japan), and is expected to maintain this dominance throughout the forecast period 2025-2034.
- Within the 7MM, men have a higher incidence of burn pain primarily due to occupational risks, as they are more likely to work in high-risk occupations such as firefighting and industrial jobs.
- Fire-related incidents are the leading cause of burn injuries in the U.S., surpassing all other causes. DelveInsight analysts categorized burn cases by etiology, including flame, contact, scald, electrical, chemical and other factors.
- More than 2 million burn injury cases will be recorded in the United States in 2023, and this number is expected to increase by 2034.
- The number of burn treatments requiring pain management therapy in the United States is estimated to be approximately 400,000 in 2023, with fluctuations expected throughout the period 2020-2034.
- In terms of gender distribution, burns will be more prevalent in men, with 290,000 cases in men and 260,000 cases in women in the United States in 2023.
- Fire-related burns account for the majority of cases of burn pain across the 7MM.
- Second-degree burns are the most common among 7MM, surpassing first-degree, third-degree, and unspecified burns, likely due to the deeper tissue involvement and higher risk of complications associated with second-degree burns.
Leading Companies in the Burn Injury Market:Johnson Johnson, Mankind Pharma, Perrigo Company PLC, Pfizer Inc., Smith Nephew PLC, Sun Pharmaceutical Industries Ltd, Trio Lifescience Pvt. Ltd, 3M, Cardinal Health, Cipla Limited, ConvaTec Group PLC, DeRoyal Industries Inc. and others are actively developing new drugs to address burn pain and improve the treatment situation.
Key Benefits of the Burn Injury Market Report:
- Comprehensive insights into burn epidemiology and market across the 7MM (US, EU5, and Japan).
- An update on current and emerging treatments for burn pain.
- Historical and forecast data on the Burn Pain market, including drug prevalence in the 7MM.
- Strategic insights that will help in developing business strategies shaped by emerging trends in the Burn Pain market.
Have a question?For more information on the Burn Pain market situation, see below.https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=reportutm_medium=promotionutm_campaign=hpr
Overview of Burn Pain
Burns are caused by factors such as heat, radiation, electricity, chemicals, friction, and other external factors. Burn pain is caused by peripheral sensory neuron damage and inflammatory responses, resulting in a complex set of symptoms, including persistent background pain and procedural pain during treatment.
Symptoms vary depending on the severity of the burn.
- First-degree burns:Redness and pain.
- Second degree burns:Swelling and discoloration.
- Third degree burns:Tissue destruction, numbness, severe damage.
Burn injuries have local and systemic effects and can affect organs and bodily functions. These injuries impose a significant physical, socio-economic and psychological burden and require comprehensive multidisciplinary management to reduce complications and promote recovery.
To learn more about the emerging treatments boosting the metastatic hr+/her2- breast cancer market, visit:https://www.delveinsight.com/report-store/burn-pain-market?utm_source=reportutm_medium=promotionutm_campaign=hpr
Burn Pain Market Outlook
Burn pain is notoriously difficult to manage due to its severity and duration. The primary goals of burn treatment are to safely and effectively relieve pain, reduce complications, preserve functional ability, and improve quality of life.
Initial treatment includes strong opioids and local anesthetics for acute pain, transitioning to peripherally acting agents such as oral opioids and NSAIDs as pain subsides. Multimodal analgesia is key, ensuring optimal analgesia with minimal side effects through appropriate dose adjustments and ongoing patient assessment.
Beyond medication, comprehensive pain management requires a multidisciplinary approach that includes psychologists, physiotherapists and pain specialists to address both the physical and psychological effects of a burn injury.
With off-label medications currently dominating the market and limited pipeline treatments available, pharmaceutical companies have a significant opportunity to develop innovative drugs with novel mechanisms of action to provide more effective and convenient treatments for burn pain.
Scope of the Burn Injury Market Report
- Study period:2020-2034
- Geographic Coverage:7MM (US, EU5: Germany, France, Italy, Spain, UK, Japan)
- Major companies:Johnson Johnson, Mankind Pharma, Perrigo Company PLC, Pfizer Inc., Smith Nephew PLC, Sun Pharmaceutical Industries Ltd, Trio Lifescience Pvt. Ltd, 3M, Cardinal Health, Cipla Limited, ConvaTec Group PLC, DeRoyal Industries Inc., and others.
- Burn Treatment Assessment:Current and emerging treatments for burn pain.
- Market dynamics:It provides Burn Pain market drivers, barriers, and competitive intelligence including SWOT analysis, PESTLE analysis, Porter's Five Forces, BCG Matrix, and market entry strategies.
- Unmet needs and what experts say:Burn Pain market access, reimbursement, and insights into the evolving trends shaping the industry.
Have questions? Click here to learn more about the Burn Pain market situation.https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=reportutm_medium=promotionutm_campaign=hpr
table of contents
- Introduction to the report
- Executive Summary
- SWOT analysis
- Overview of percentage of burn patients
- Overview of Burnt Pain Market
- Background and overview of burn pain disorders
- Epidemiology and prevalence of burns
- Number of burn patients by country
- Current Treatments and Medical Procedures for Burn Pain
- Unmet Needs
- New treatment for burns
- Burn Market Outlook
- Burn Market Analysis by Country (2020-2034)
- Market Access and Reimbursement of Therapies
- Market Drivers
- Market Barriers
- Appendix
- Burn Reporting Methodology
- DelveInsight Features
- Disclaimer
- About DelveInsight
About DelveInsight
DelveInsight is a market research and consulting company specializing in the healthcare and life sciences sector, providing accurate market intelligence to support clients' business strategies. Our team of experienced experts analyzes the latest trends in the pharmaceutical, medical technology and biotechnology sectors and provides optimal solutions to companies across the globe.
Contact Information:
Himanshu
hmason@delveinsight.com
info@delveinsight.com
+14699457679
